Gadoxetic Acid–enhanced MRI Scoring Model to Predict Pathologic Features of Hepatocellular Carcinoma
Kun Zhang, Kan He, Lei Zhang, Wencui Li, Shuangshuang Xie, Ying-Zhu Cui, Li-Ying Lin, Zhiwei Shen, Shuang Xia, Xiaomin Su, Huimao Zhang, Zhaoxiang Ye, Wen Shen
Abstract
= .002). A combined model including the I-score and two other predictors demonstrated superior prognostic performance (C index, 0.84 [95% CI: 0.74, 0.91]). Conclusion The developed scoring model based on gadoxetic acid-enhanced MRI enabled noninvasive preoperative prediction of HCC high-risk pathologic features and early recurrence. © RSNA, 2025
Topics & Concepts
Gadoxetic acidMedicineHepatocellular carcinomaRadiologyMagnetic resonance imagingGadolinium DTPAScoring systemCarcinomaInternal medicineLiver Disease Diagnosis and TreatmentHepatocellular Carcinoma Treatment and PrognosisCancer, Lipids, and Metabolism